Eastman Chemical Company
EMN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | -3.7% | -0.1% | 2% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $2 |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 19.7% | 22.1% | 24.8% | 24.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 9.5% | 12.4% | 13.9% | 16.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 2.1% | 6.1% | 7.9% | 14.7% |
| EPS | 0.41 | 1.22 | 1.58 | 2.85 |
| % Growth | -66.4% | -22.8% | -44.6% | – |
| EPS Diluted | 0.41 | 1.2 | 1.57 | 2.82 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 8.5% | 15.4% | 18.9% | 21.5% |